Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

APOA2 Antikörper (AA 23-56)

Der Kaninchen Polyklonal Anti-APOA2-Antikörper wurde für WB validiert. Er ist geeignet, APOA2 in Proben von Human zu detektieren. Es sind 5+ Publikationen verfügbar.
Produktnummer ABIN1881065

Kurzübersicht für APOA2 Antikörper (AA 23-56) (ABIN1881065)

Target

Alle APOA2 Antikörper anzeigen
APOA2 (Apolipoprotein A-II (APOA2))

Reaktivität

  • 77
  • 33
  • 14
  • 8
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
Human

Wirt

  • 74
  • 11
  • 10
  • 2
  • 2
  • 1
Kaninchen

Klonalität

  • 80
  • 20
Polyklonal

Konjugat

  • 51
  • 13
  • 10
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser APOA2 Antikörper ist unkonjugiert

Applikation

  • 60
  • 43
  • 29
  • 25
  • 19
  • 13
  • 13
  • 12
  • 9
  • 7
  • 6
  • 4
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
Western Blotting (WB)
  • Bindungsspezifität

    • 20
    • 5
    • 4
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 23-56

    Homologie

    Pr

    Aufreinigung

    This antibody is purified through a protein A column, followed by peptide affinity purification.

    Immunogen

    This APOA2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 23-56 amino acids from the Central region of human APOA2.

    Isotyp

    Ig Fraction
  • Applikationshinweise

    WB: 1:1000

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Buffer

    Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    4 °C,-20 °C

    Haltbarkeit

    6 months
  • Lackner, Law, Brewer: "The human apolipoprotein A-II gene: complete nucleic acid sequence and genomic organization." in: Nucleic acids research, Vol. 13, Issue 12, pp. 4597-608, (1985) (PubMed).

    Knott, Wallis, Robertson, Priestley, Urdea, Rall, Scott: "The human apolipoprotein AII gene: structural organization and sites of expression." in: Nucleic acids research, Vol. 13, Issue 17, pp. 6387-98, (1985) (PubMed).

    Knott, Priestley, Urdea, Scott: "Isolation and characterisation of a cDNA encoding the precursor for human apolipoprotein AII." in: Biochemical and biophysical research communications, Vol. 120, Issue 3, pp. 734-40, (1984) (PubMed).

    Moore, Kao, Tsao, Chan: "Human apolipoprotein A-II: nucleotide sequence of a cloned cDNA, and localization of its structural gene on human chromosome 1." in: Biochemical and biophysical research communications, Vol. 123, Issue 1, pp. 1-7, (1984) (PubMed).

    Sharpe, Sidoli, Shelley, Lucero, Shoulders, Baralle: "Human apolipoproteins AI, AII, CII and CIII. cDNA sequences and mRNA abundance." in: Nucleic acids research, Vol. 12, Issue 9, pp. 3917-32, (1984) (PubMed).

  • Target

    APOA2 (Apolipoprotein A-II (APOA2))

    Andere Bezeichnung

    APOA2

    Hintergrund

    May stabilize HDL (high density lipoprotein) structure by its association with lipids, and affect the HDL metabolism.

    Molekulargewicht

    11175

    NCBI Accession

    NP_001634

    UniProt

    P02652

    Pathways

    Regulation of Lipid Metabolism by PPARalpha, Production of Molecular Mediator of Immune Response, Negative Regulation of Transporter Activity, Lipid Metabolism
Sie sind hier:
Chat with us!